
ULCERATIVE-NECROTIZING ANGIITIS ON A BACKGROUND OF RECEPTION OF LENVATINIB IN THYROID CANCER
Author(s) -
Ekaterina V. Orlova,
O. V. Grabovskaya,
Л. М. Смирнова,
Л. А. Шестакова,
N. I. Melikova,
Lyailya N. Kayumova
Publication year - 2019
Publication title -
rossijskij žurnal kožnyh i veneričeskih boleznej
Language(s) - English
Resource type - Journals
eISSN - 2412-9097
pISSN - 1560-9588
DOI - 10.17816/dv42933
Subject(s) - medicine , lenvatinib , pathogenesis , cancer , thyroid cancer , thyroid , vasculitis , pathology , dermatology , disease
The information about modern targeted drugs used in chemotherapy regimens for different types of cancer is presented. The mechanisms of pathogenesis of the development of undesirable skin reactions in the presence of tyrosine kinase receptor inhibitors are described. The clinical case of a rarely occurring reaction to drugs inhibitors of vascular growth factor in the form of ulcerative-necrotic skin lesions in a 63-year-old patient is presented.